GB0624082D0 - Ramipril metal salts - Google Patents

Ramipril metal salts

Info

Publication number
GB0624082D0
GB0624082D0 GBGB0624082.4A GB0624082A GB0624082D0 GB 0624082 D0 GB0624082 D0 GB 0624082D0 GB 0624082 A GB0624082 A GB 0624082A GB 0624082 D0 GB0624082 D0 GB 0624082D0
Authority
GB
United Kingdom
Prior art keywords
ramipril
metal salts
salts
metal
ramipril metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0624082.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selamine Ltd
Original Assignee
Selamine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selamine Ltd filed Critical Selamine Ltd
Priority to GBGB0624082.4A priority Critical patent/GB0624082D0/en
Publication of GB0624082D0 publication Critical patent/GB0624082D0/en
Priority to PCT/GB2007/004604 priority patent/WO2008065421A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0624082.4A 2006-12-01 2006-12-01 Ramipril metal salts Ceased GB0624082D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0624082.4A GB0624082D0 (en) 2006-12-01 2006-12-01 Ramipril metal salts
PCT/GB2007/004604 WO2008065421A1 (en) 2006-12-01 2007-11-30 Ramipril-metal salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0624082.4A GB0624082D0 (en) 2006-12-01 2006-12-01 Ramipril metal salts

Publications (1)

Publication Number Publication Date
GB0624082D0 true GB0624082D0 (en) 2007-01-10

Family

ID=37671733

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0624082.4A Ceased GB0624082D0 (en) 2006-12-01 2006-12-01 Ramipril metal salts

Country Status (2)

Country Link
GB (1) GB0624082D0 (en)
WO (1) WO2008065421A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23149A (en) 2009-09-21 2011-03-31 Silverstone Pharma New benzatin salts of ace inhibitors, procedure for their preparationand their application for treatment of cardiovascular diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391462A1 (en) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Synergistic compositions containing ketanserin
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
DE10038364A1 (en) * 2000-08-05 2002-05-02 Hexal Ag Pharmaceutical effervescent formulation containing ramipril
US20050118259A1 (en) * 2002-01-15 2005-06-02 Renir Eyjolfsson Formulations of quinapril and related ace nhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
GB2411355B (en) * 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
WO2008065421A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
ZA200808639B (en) Oxadiazolidinedione compound
IL179344A0 (en) Tracking method
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1985620A4 (en) 10a-AZALIDE COMPOUND
EP1984379A4 (en) Anti-arenaviral compounds
EP2000469A4 (en) Acylaminopiperidine compound
HU0600293D0 (en) New rosuvastatine salt
GB0607096D0 (en) Compound
EP2082022A4 (en) Compounds
GB0624087D0 (en) Ramipril combination salt
GB0624090D0 (en) Ramipril amine salts
EP2004174A4 (en) Naphthalenedione compounds
GB0604142D0 (en) Compound
GB0602042D0 (en) Compounds
EP1973905A4 (en) Compounds
GB0624082D0 (en) Ramipril metal salts
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (en) Bis-pyridinium compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
PL379138A1 (en) Photopolymerizing compound
GB0603894D0 (en) Compound
GB0607251D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)